Condensed Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)	Series A Preferred Stock [Member] Preferred Stock [Member]	Series B Preferred Stock [Member] Preferred Stock [Member]	Common Stock [Member]	Common Stock to be Issued [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2020	$ 3,000	$ 4,440	$ 17,483	$ 1,652	$ 13,417,073	$ (13,892,754)	$ (449,106)
Beginning balance, shares at Dec. 31, 2020	3,000,000	4,440,000	17,483,283	1,651,458
Conversion of Series A Preferred Stock to common stock to be issued	$ (3,000)			$ 6,000	(3,000)
Conversion of Series A Preferred Stock to common stock to be issued, shares	(3,000,000)			6,000,000
Conversion of Series B Preferred Stock to common stock to be issued		$ (4,440)		$ 4,440
Conversion of Series B Preferred Stock to common stock to be issued, shares		(4,440,000)		4,440,000
Common stock issued from common stock to be issued			$ 24	$ (24)
Common stock issued from common stock to be issued, shares			24,000	(24,000)
Stock-based compensation expense					1,082		1,082
Net income						50,230	50,230
Ending balance, value at Mar. 31, 2021			$ 17,507	$ 12,068	13,415,155	(13,842,524)	(397,794)
Ending balance, shares at Mar. 31, 2021			17,507,283	12,067,458
Beginning balance, value at Dec. 31, 2021			$ 19,747	$ 12,068	13,976,159	(14,129,625)	(121,651)
Beginning balance, shares at Dec. 31, 2021			19,747,283	12,067,458
Common stock issued from common stock to be issued			$ 11,441	$ (11,441)
Common stock issued from common stock to be issued, shares			11,441,177	(11,440,177)
Stock-based compensation expense					1,081		1,081
Net income						(167,047)	(167,047)
Ending balance, value at Mar. 31, 2022			$ 31,188	$ 627	$ 13,977,240	$ (14,296,672)	$ (287,617)
Ending balance, shares at Mar. 31, 2022			31,188,460	627,281